Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDRY.L Regulatory News (SDRY)

  • There is currently no data for SDRY

Director/PDMR Shareholding

16 Aug 2019 09:43

RNS Number : 3181J
Superdry PLC
16 August 2019
Β 

SuperdryPlc

Β 

Β ("Superdry" or "the Company")

Β 

16 August 2019

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMR") and persons closely associated with them ("PCA")

Β 

On 16 August 2019, the PDMRs named below were granted options to acquire the number of ordinary shares of 5 pence each ("Ordinary Shares") in the capital of Superdry set out opposite their names under the terms of the Superdry Sharesave Scheme ("SAYE") at a fixed option price of Β£3.39 pence per Ordinary Share.

Β 

Name / Position of PDMR

Number of Ordinary Shares over which the option is held

Nick Gresham - Chief Financial Officer

5,309

Gordon Knox - Logistics Director

5,309

Shaun Packe - Sourcing Director

5,309

Jon Wragg - Wholesale & E-Commerce Director

5,309

Β 

The transactions were notified to the Company by the PDMRs on 16 August 2019.

Β 

This announcement, including the notification(s) below, is made in accordance with the requirements of the EU Market Abuse Regulation.

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

1. Nick Gresham

2. Gordon Knox

3. Shaun Packe

4. Jon Wragg

Β 

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

1. Chief Financial Officer/PDMR

2. Logistics Director/PDMR

3. Sourcing Director/PDMR

4. Wholesale & E-Commerce Director/PDMR

Β 

b)

Β 

Initial notification /Amendment

Β 

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Superdry Plc

b)

Β 

LEI

Β 

213800GAQMT2WL7BW361

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 5 pence each

Β 

Β 

ISIN: GB00B60BD277

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Grant of options to acquire shares under the Superdry Sharesave Scheme.

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

1. Β£3.39

2. Β£3.39

3. Β£3.39

4. Β£3.39

Β 

1. 5,309

2. 5,309

3. 5,309

4. 5,309

Β 

d)

Β 

Aggregated information

Β 

Β 

Price(s)

Β 

Aggregated volume (s)

1. Β£17,997.51

2. Β£17,997.51

3. Β£17,997.51

4. Β£17,997.51

Β 

1. 5,309

2. 5,309

3. 5,309

4. 5,309

Β 

e)

Β 

Date of the transaction

Β 

16 August 2019

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

Β 

Β 

Β 

For further information:

Β 

Superdry Plc

Simon Callander

Group General Counsel and Company Secretary

+44 (0) 1242 586643

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHGGUUCRUPBURQ
Date   Source Headline
28th Aug 20203:00 pmRNSTotal Voting Rights
25th Aug 202012:02 pmRNSPrice Monitoring Extension
14th Aug 202011:00 amRNSDirector/PDMR Shareholding
10th Aug 20207:00 amRNSStatement re : New financing facility and trading
31st Jul 202011:00 amRNSTotal Voting Rights
24th Jul 20204:41 pmRNSSecond Price Monitoring Extn
24th Jul 20204:36 pmRNSPrice Monitoring Extension
23rd Jul 20209:34 amRNSHolding(s) in Company
21st Jul 202011:38 amRNSHolding(s) in Company
21st Jul 202011:29 amRNSHolding(s) in Company
20th Jul 20202:12 pmRNSHolding(s) in Company
14th Jul 202010:03 amRNSDirector/PDMR Shareholding
2nd Jul 202010:34 amRNSHolding(s) in Company
2nd Jul 202010:23 amRNSHolding(s) in Company
2nd Jul 20209:47 amRNSHolding(s) in Company
30th Jun 202010:21 amRNSTotal Voting Rights
29th Jun 20209:20 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:36 pmRNSPrice Monitoring Extension
18th Jun 20207:00 amRNSStatement re China Joint Venture
16th Jun 20209:14 amRNSDirector/PDMR Shareholding
2nd Jun 202011:29 amRNSHolding(s) in Company
29th May 202012:02 pmRNSPrice Monitoring Extension
29th May 20209:28 amRNSTotal Voting Rights
26th May 202012:02 pmRNSPrice Monitoring Extension
22nd May 20204:15 pmRNSHolding(s) in Company
15th May 20204:41 pmRNSSecond Price Monitoring Extn
15th May 20204:36 pmRNSPrice Monitoring Extension
14th May 20209:48 amRNSDirector/PDMR Shareholding
12th May 202012:02 pmRNSPrice Monitoring Extension
7th May 20207:00 amRNSTrading Statement
30th Apr 20202:00 pmRNSTotal Voting Rights
22nd Apr 202012:07 pmRNSSecond Price Monitoring Extn
22nd Apr 202012:02 pmRNSPrice Monitoring Extension
15th Apr 20202:15 pmRNSDirector/PDMR Shareholding
9th Apr 20209:00 amRNSDirector Declaration
3rd Apr 20209:04 amRNSHolding(s) in Company
31st Mar 202011:28 amRNSTotal Voting Rights
31st Mar 202010:46 amRNSHolding(s) in Company
27th Mar 20204:37 pmRNSPrice Monitoring Extension
26th Mar 202012:02 pmRNSPrice Monitoring Extension
25th Mar 20204:42 pmRNSSecond Price Monitoring Extn
25th Mar 20204:37 pmRNSPrice Monitoring Extension
24th Mar 202010:15 amRNSHolding(s) in Company
23rd Mar 20202:34 pmRNSBlock listing Interim Review
18th Mar 20207:00 amRNSStatement re Current trading and COVID-19 update
16th Mar 202010:42 amRNSDirector/PDMR Shareholding
4th Mar 20209:21 amRNSHolding(s) in Company
2nd Mar 20204:17 pmRNSHolding(s) in Company
28th Feb 20208:54 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.